Global Feature
A Pharmaceutical Ingredients Outlook
Patricia Van Arnum, senior editor, Pharmaceutical Technology and editor of Sourcing and Management
Despite a challenging current economic environment, the five-year outlook for pharmaceutical outsourcing and ingredients supply is fairly healthy.
Biotech
Financing Outlook for the US Biotechnology Industry
Patricia Van Arnum, senior editor, Pharmaceutical Technology and editor of Sourcing and Management
Buoyed by an uptick in financing from partnering deals, the US biotechnology industry reached a record high in private and public financing in 2009, but caution remains for 2010.
Outsourcing
Squeezed for Cash
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
7th Annual Biomanufacturing Survey: Participation Request
As part of Pharmceutical Technology’s goal of supporting the biopharmaceutical community, we have partnered with BioPlan Associates, Inc. to collect data for the 7th Annual Report and Survey of Biopharmaceutical Manufacturing. This global benchmarking study measures today's most important trends and shifts in biomanufacturing. Please take the opportunity to share your opinions and perspectives for this important international study. You will be ensuring that this industry is properly measuring today's issues such as capacity utilization, batch failure rates, outsourcing, disposables usage, expression systems, hiring and training, and many others.
• Please participate to ensure the Biopharmaceutical community is properly represented in this global study.
• You will also receive free summary of the results.
To participate in the survey, please click here.
|